Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

NCT00299780 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Multiple Myeloma
Acute Myelogenous Leukemia

Interventions

DRUG: Stem cell mobilization

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]